Filtered By:
Drug: Zocor
This page shows you your search results in order of date.
Order by Relevance | Date
Total 142 results found since Jan 2013.
Statins and immune-mediated necrotizing myopathy: Variability in the risk
CONCLUSION: Atorvastatin presents the highest risk of IMNM. Our data suggest that the occurrence of IMNM is a class effect.PMID:37625939 | DOI:10.1016/j.therap.2023.07.005
Source: Therapie - August 25, 2023 Category: Psychiatry & Psychology Authors: Thierry Trenque Jed Hadjoudj Agathe Trenque Federica Tralongo Salom é Martin Brahim Azzouz Source Type: research
Statin associated Muscular Adverse Effects
CONCLUSION: Early recognition of muscle symptoms is required to prevent rhabdomyolysis. Further researchare needed to completely elucidate the pathophysiology of statin-induced muscular adverse effects.PMID:36847228 | DOI:10.2174/1574886318666230227143627
Source: Current Drug Safety - February 27, 2023 Category: Drugs & Pharmacology Authors: Rania Kammoun Ons Charfi Ghozlane Lakhoua Ahmed Zaiem Riadh Daghfous Sarrah Kastalli Imen Aouinti Sihem El Aidli Source Type: research
Progressive proximal muscle weakness with subacute onset in an elderly patient: a case report
CONCLUSION: In this case, exclusion of inflammatory myopathies, metabolic muscle disorders and other neurological diseases is necessary for establishing a reliable diagnosis. In SINAM, simply discontinuing statin is often insufficient and aggressive immunosuppression or immunomodulation therapy is needed to achieve disease remission. This case aims to demonstrate that statins can induce serious muscular diseases that require aggressive immunosuppression.PMID:36544374 | DOI:10.33588/rn.7601.2021276
Source: Revista de Neurologia - December 22, 2022 Category: Neurology Authors: A Martins G Nadais M Pinto R Taipa L Costa S Pimenta Source Type: research
